zolacabtagene autoleucel (BMS-986353) - BMS
cyclophosphamide - Generic mfg.
fludarabine IV - Generic mfg.
CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis (clinicaltrials.gov) - Sep 11, 2026 - P1/2 | N=12 | Active, not recruiting | Sponsor: Marcela V. Maus, M.D.,Ph.D. | Recruiting ➔ Active, not recruiting | Initiation date: Jul 2026 ➔ Mar 2026 
Enrollment closed • Trial initiation date • ANCA Vasculitis • Vasculitis • MPO
http://clinicaltrials.gov/ct2/show/NCT07388277
 
Sep 11, 2026
 
Prev Next